Dr. Suzanne Koven from the Massachusetts General Hospital in Boston explores the reasons why primary care physicians (herself included) are unlikely to prescribe weight-loss medications to their obese patients.
Qsymia, the combination diet drug composed of phentermine and topiramate, was approved by the FDA in July of 2012. Now, the results of a study conducted between December 2007 and September 2008 and
